FOXO Technologies Inc. Completes Reverse Stock Split

FOXO Technologies Inc., a software company specializing in underwriting protocol and consumer engagement platforms based on epigenetic technology, has announced the completion of a reverse stock split. The company operates globally, serving insurers, health researchers, and life science companies.

The reverse stock split comes after a year of significant stock price fluctuations. The company’s stock reached a 52-week high of $13 USD on November 11, 2024, and a 52-week low of $0.696 USD on May 4, 2025. As of the latest update, the stock price stands at $0.723 USD, indicating a relatively stable trend following the split.

The financial metrics of FOXO Technologies Inc. reflect a complex valuation landscape. The price-to-earnings ratio is currently -0.093335, while the price-to-book ratio is 0.37219. These figures suggest that investors and analysts may need to consider various factors when evaluating the company’s financial health and future prospects.

FOXO Technologies Inc. is listed on the NYSE American, and its operations are conducted in USD. The company’s recent reverse stock split is a strategic move aimed at adjusting its stock price and potentially attracting a different investor base. As the company continues to innovate in its field, it remains a key player in the intersection of technology and life sciences.